No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990
- PMID: 12899557
- DOI: 10.1080/00016470310014292
No improvement in the overall survival of 194 patients with chondrosarcoma in Finland in 1971-1990
Abstract
We describe the clinicopathologic profile and survival of 306 patients with chondrosarcoma reported to the Finnish Cancer Registry in 1971-1990. 218 cases were available for reevaluation. Owing to their various clinicopathologic characteristics, we excluded the histologic variants of chondrosarcoma. Therefore, the final study population included 194 patients. The minimum follow-up was 9 years. The study population included 69 grade 1 tumors, 114 grade 2 tumors, and 11 grade 3 tumors. The commonest tumor sites were the chest, pelvis and femur. A local recurrence developed in 25% of the patients and metastatic lesions in 18%. The patients were treated in 31 hospitals (in 22 hospitals during the 1970s and in 26 in the 1980s), and the number of patients biopsied before the referral remained about the same from the 1970s (15%) to the 1980s (18%). The 5-and 10-year disease-specific survival rates were 70% and 57%, respectively. Multivariate analysis showed that the most important independent predictors of shortened survival were high histologic grade, age 50 years or older, and a diagnosis in the 1980s, as compared to the 1970s. Most findings accorded with reports from specialist treatment centers, but to our surprise, the survival rate declined among patients diagnosed in the 1980s versus the 1970s. The failure to improve patient survival is probably due to treatment of the patients in 31 hospitals rather than in a few centers dealing with treatment of cancer.
Similar articles
-
Osteosarcoma in Finland from 1971 through 1990: a nationwide study of epidemiology and outcome.Acta Orthop. 2008 Dec;79(6):861-6. doi: 10.1080/17453670810016966. Acta Orthop. 2008. PMID: 19085506
-
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20. Int J Urol. 2009. PMID: 19207609
-
Management and outcome of recurrent well-differentiated thyroid carcinoma.Arch Otolaryngol Head Neck Surg. 2004 Jul;130(7):819-24. doi: 10.1001/archotol.130.7.819. Arch Otolaryngol Head Neck Surg. 2004. PMID: 15262757
-
Primary malignant tumors of the chest wall. The Memorial Sloan-Kettering Cancer Center experience.Chest Surg Clin N Am. 1994 Feb;4(1):137-54. Chest Surg Clin N Am. 1994. PMID: 8055278 Review.
-
Dedifferentiated chondrosarcoma revisited.J Surg Orthop Adv. 2011 Summer;20(2):106-11. J Surg Orthop Adv. 2011. PMID: 21838071 Review.
Cited by
-
Risk analysis of pulmonary metastasis of chondrosarcoma by establishing and validating a new clinical prediction model: a clinical study based on SEER database.BMC Musculoskelet Disord. 2021 Jun 9;22(1):529. doi: 10.1186/s12891-021-04414-2. BMC Musculoskelet Disord. 2021. PMID: 34107945 Free PMC article.
-
Malawer limb salvage surgery for the treatment of scapular chondrosarcoma.World J Surg Oncol. 2014 Jun 30;12:196. doi: 10.1186/1477-7819-12-196. World J Surg Oncol. 2014. PMID: 24976133 Free PMC article.
-
CXCR4-targeted therapy inhibits VEGF expression and chondrosarcoma angiogenesis and metastasis.Mol Cancer Ther. 2013 Jul;12(7):1163-70. doi: 10.1158/1535-7163.MCT-12-1092. Epub 2013 May 17. Mol Cancer Ther. 2013. PMID: 23686836 Free PMC article.
-
Aberrant DNA methylations in chondrosarcoma.Epigenomics. 2016 Nov;8(11):1519-1525. doi: 10.2217/epi-2016-0071. Epub 2016 Sep 30. Epigenomics. 2016. PMID: 27686001 Free PMC article. Review.
-
[Cartilage tumours of the bone. Diagnosis and therapy].Orthopade. 2006 Aug;35(8):871-81; quiz 882. doi: 10.1007/s00132-006-0991-1. Orthopade. 2006. PMID: 16865383 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Medical